DIAGENS-B Proposes Implementation of Share Incentive Scheme

Stock News04-29

DIAGENS-B (02526) has announced that its board of directors passed a resolution during a meeting held on April 29, 2026, recommending the adoption of a share incentive plan. The plan aims to foster the company's long-term sustainable development, attract and retain qualified participants who contribute to the group's sustained growth and success, align the interests of incentive recipients, shareholders, and the company, and optimize the corporate incentive structure. Grants of restricted share units and share options will be funded through the following methods: H shares purchased by a trustee on the secondary market; new H shares to be issued by the company; and treasury shares legally held by the company, if any.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment